| 184475-35-2 Basic information More.. |
Product Name: | Gefitinib | Synonyms: | N-(3-Chloro-4-fluoro-phenyl)-7-methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4-amine Gefitinib;Gefitinib, >=99%;GEFITINIB RELATED COMPOUND;Gefitinib
N-(3-Chloro-4-fluoro-phenyl)-7-methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4-amine;GEFITINIB;n-(3-chloro-4-fluoro-phenyl)-7-methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4-amine;ZD 1839;4-Quinazolinamine, N-(3-chloro-4-fluorophenyl)-7-methoxy-6-[3-(4-morpholinyl)propoxy]- | CAS: | 184475-35-2 | MF: | C22H24ClFN4O3 | MW: | 446.9 | EINECS: | 643-034-7 | Mol File: | 184475-35-2.mol | |
Use
Gefitinib was introduced in japan as a daily oral monotherapy for the treatment of inoperable or recurrent non-small cell lung cancers (nsclc).
- Gefitinib
-
- US $0.00-0.00 / kgkg
- 2024-09-20
- CAS:184475-35-2
- Min. Order: 1kgkg
- Purity: 99%(HPLC)
- Supply Ability: 2 tons
- Gefitinib
-
- US $0.00 / g
- 2024-09-20
- CAS:184475-35-2
- Min. Order: 1g
- Purity: More Than 99%
- Supply Ability: 100kg/Month
- Gefitinib
-
- US $5.70 / kg
- 2024-09-19
- CAS:184475-35-2
- Min. Order: 10kg
- Purity: 99%
- Supply Ability: 10000kg
|
184475-35-2
Recommend Suppliers |
|